BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29340726)

  • 1. Prognostic Prediction Models for Resection of Large Hepatocellular Carcinoma: A Korean Multicenter Study.
    Hwang S; Joh JW; Wang HJ; Kim DG; Kim KS; Suh KS; Kim SH; Yu HC; Cho CK; Lee YJ; Kim KH; Kim JM; Kim BW; Lee SG
    World J Surg; 2018 Aug; 42(8):2579-2591. PubMed ID: 29340726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplication of Tumor Volume by Two Tumor Markers Is a Post-Resection Prognostic Predictor for Solitary Hepatocellular Carcinoma.
    Hwang S; Song GW; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Lee SG
    J Gastrointest Surg; 2016 Nov; 20(11):1807-1820. PubMed ID: 27311982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.
    Meguro M; Mizuguchi T; Nishidate T; Okita K; Ishii M; Ota S; Ueki T; Akizuki E; Hirata K
    World J Gastroenterol; 2015 Apr; 21(16):4933-45. PubMed ID: 25945007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Outcome After Resection of Huge Hepatocellular Carcinoma ≥ 10 cm: Single-Institution Experience with 471 Patients.
    Hwang S; Lee YJ; Kim KH; Ahn CS; Moon DB; Ha TY; Song GW; Jung DH; Lee SG
    World J Surg; 2015 Oct; 39(10):2519-28. PubMed ID: 26126423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small Hepatocellular Carcinoma With Low Tumor Marker Expression Benefits More From Anatomical Resection Than Tumors With Aggressive Biology.
    Jung DH; Hwang S; Lee YJ; Kim KH; Song GW; Ahn CS; Moon DB; Lee SG
    Ann Surg; 2019 Mar; 269(3):511-519. PubMed ID: 28837444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma?
    Cheung TT; Chan SC; Ho CL; Chok KS; Chan AC; Sharr WW; Ng KK; Poon RT; Lo CM; Fan ST
    Liver Transpl; 2011 Oct; 17(10):1218-25. PubMed ID: 21688383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of preoperative fluorodeoxyglucose-positron emission tomography in prediction of tumor recurrence after liver transplantation for hepatocellular carcinoma patients: a Japanese multicenter study.
    Takada Y; Kaido T; Shirabe K; Nagano H; Egawa H; Sugawara Y; Taketomi A; Takahara T; Wakabayashi G; Nakanishi C; Kawagishi N; Kenjo A; Gotoh M; Toyoki Y; Hakamada K; Ohtsuka M; Akamatsu N; Kokudo N; Takeda K; Endo I; Takamura H; Okajima H; Wada H; Kubo S; Kuramitsu K; Ku Y; Ishiyama K; Ohdan H; Ito E; Maehara Y; Honda M; Inomata Y; Furukawa H; Uemoto S; Yamaue H; Miyazaki M; Takada T;
    J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):49-57. PubMed ID: 27806426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of prognostic factors on recurrence after curative resections for hepatocellular carcinoma.
    Han JH; Kim DG; Na GH; Kim EY; Lee SH; Hong TH; You YK
    World J Gastroenterol; 2014 Dec; 20(45):17132-40. PubMed ID: 25493027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinical Implications of Liver Resection Margin Size in Patients with Hepatocellular Carcinoma in Terms of Positron Emission Tomography Positivity.
    Park JH; Kim DH; Kim SH; Kim MY; Baik SK; Hong IS
    World J Surg; 2018 May; 42(5):1514-1522. PubMed ID: 29026966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Accuracy of the ADV Score Following Resection of Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis.
    Hwang S; Moon DB; Kim KH; Ahn CS; Song GW; Jung DH; Park GC; Lee SG
    J Gastrointest Surg; 2021 Jul; 25(7):1745-1759. PubMed ID: 32948961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of quantitative prognostic prediction using ADV score for resection of hepatocellular carcinoma: A Korea-Japan collaborative study with 9200 patients.
    Kang WH; Hwang S; Kaibori M; Kim JM; Kim KS; Kobayashi T; Kayashima H; Koh YS; Kubota K; Mori A; Takeda Y; Yun SS; Matsui K; Toriguchi K; Nagano H; Yoon MH; Soejima Y; Ariizumi S; Kim BS; Park Y; Yu HC; Kim BW; Lee JB; Park SJ; Jang JY; Yamaue H; Nakamura M; Yamamoto M; Endo I; ;
    J Hepatobiliary Pancreat Sci; 2023 Aug; 30(8):993-1005. PubMed ID: 36808234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of Post-resection Prognosis Using the ADV Score for Huge Hepatocellular Carcinomas ≥13 cm.
    Hwang S; Kim KH; Moon DB; Ahn CS; Ha TY; Song GW; Jung DH; Park GC
    J Liver Cancer; 2021 Mar; 21(1):45-57. PubMed ID: 37384269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Volumetric parameters on FDG PET can predict early intrahepatic recurrence-free survival in patients with hepatocellular carcinoma after curative surgical resection.
    Lee JW; Hwang SH; Kim HJ; Kim D; Cho A; Yun M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1984-1994. PubMed ID: 28695236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha fetoprotein changes predict hepatocellular carcinoma survival beyond the Milan criteria after hepatectomy.
    Shen JY; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
    J Surg Res; 2017 Mar; 209():102-111. PubMed ID: 28032546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A survival benefit of major hepatectomy for hepatocellular carcinoma identified by preoperative [18F] fluorodeoxyglucose positron emission tomography in patients with well-preserved hepatic function.
    Ahn SG; Jeon TJ; Lee SD; Kim SH; Cho HJ; Yun M; Park YN; Lee JD; Park SJ; Kim KS
    Eur J Surg Oncol; 2013 Sep; 39(9):964-73. PubMed ID: 23859893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-fetoprotein and (18)F-FDG positron emission tomography predict tumor recurrence better than Milan criteria in living donor liver transplantation.
    Hong G; Suh KS; Suh SW; Yoo T; Kim H; Park MS; Choi Y; Paeng JC; Yi NJ; Lee KW
    J Hepatol; 2016 Apr; 64(4):852-9. PubMed ID: 26658686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of postoperative adjuvant transcatheter arterial chemoembolization on hepatocellular carcinoma.
    Liu C; Sun L; Xu J; Zhao Y
    World J Surg Oncol; 2016 Apr; 14():100. PubMed ID: 27038790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with non-[18 F]fludeoxyglucose-avid advanced hepatocellular carcinoma on clinical staging may achieve long-term recurrence-free survival after liver transplantation.
    Kornberg A; Küpper B; Tannapfel A; Büchler P; Krause B; Witt U; Gottschild D; Friess H
    Liver Transpl; 2012 Jan; 18(1):53-61. PubMed ID: 21850692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes of hepatectomy for stage B Hepatocellular carcinoma in the BCLC classification.
    Kamiyama T; Orimo T; Wakayama K; Shimada S; Nagatsu A; Yokoo H; Kamachi H; Yamashita K; Shimamura T; Taketomi A
    World J Surg Oncol; 2017 Aug; 15(1):156. PubMed ID: 28830473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resection of peritoneal implantation of hepatocellular carcinoma after hepatic resection: risk factors and prognostic analysis.
    Yeh CN; Chen MF
    World J Surg; 2004 Apr; 28(4):382-6. PubMed ID: 14994148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.